But, in the interim, patients deserve, at the very least, accurate information so they, and their healthcare provider, can make informed decisions about their health
J., Braymer, H
Lancet 394:131138 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC
That makes physician supervision, side-effect monitoring, medication legitimacy, muscle preservation, and long-term maintenance even more important
Ask about anti-nausea medication